Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial

2008 ◽  
Vol 2008 ◽  
pp. 44-45
Author(s):  
L.P. Shulman
Keyword(s):  
Preterm Birth ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Vaginal Gel

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial

2007 ◽  
Vol 30 (5) ◽  
pp. 687-696 ◽  
Author(s):  
J. M. O'Brien ◽  
C. D. Adair ◽  
D. F. Lewis ◽  
D. R. Hall ◽  
E. A. DEfranco ◽  
...  
Keyword(s):  
Preterm Birth ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Vaginal Gel

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial

2018 ◽  
Vol 18 (11) ◽  
pp. 1241-1250 ◽  
Author(s):  
Sinead Delany-Moretlwe ◽  
Carl Lombard ◽  
Deborah Baron ◽  
Linda-Gail Bekker ◽  
Busi Nkala ◽  
...  
Keyword(s):  
South Africa ◽  
Controlled Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Vaginal Gel ◽  
Hiv 1 ◽  
Prevention Of Hiv

Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled trial

Maturitas ◽  
2014 ◽  
Vol 78 (3) ◽  
pp. 205-211 ◽  
Author(s):  
Sônia Maria Rolim Rosa Lima ◽  
Bianca Franco Augusto Bernardo ◽  
Silvia Saito Yamada ◽  
Benedito Fabiano Reis ◽  
Gustavo Maximiliano Dutra da Silva ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Glycine Max ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
Receptor Expression ◽  
Estrogen Receptor Expression ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Vaginal Gel ◽  
Glycine Max L
Sign in / Sign up

Export Citation Format

Share Document